Inflammatory events during murine squamous cell carcinoma development

• Published in: Journal of inflammation (London, England) Vol. 9; no. 1; p. 46
• Main Authors: Gasparoto, Thais Helena, de Oliveira, Carine Ervolino, de Freitas, Luisa Thomazini, Pinheiro, Claudia Ramos, Ramos, Rodrigo Nalio, da Silva, André Luis, Garlet, Gustavo Pompermaier, da Silva, João Santana, Campanelli, Ana Paula
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 23.11.2012; BioMed Central; BMC
• Subjects: Analysis; Bone morphogenetic proteins; Cancer; Chemokines; Colleges & universities; Cytokines; Development and progression; DNA damage; Elastase; Experiments; Immune response; Inflammatory cells; Kinases; Macrophages; Myeloperoxidase; Nitric oxide; Rodents; Skin; Squamous cell carcinoma; Technological change; Transforming growth factors; Tumor necrosis factor; California
• ISSN: 1476-9255; 1476-9255
• DOI: 10.1186/1476-9255-9-46

Squamous cell carcinoma (SCC) is one of the most common human cancers worldwide. In SCC, tumour development is accompanied by an immune response that leads to massive tumour infiltration by inflammatory cells, and consequently, local and systemic production of cytokines, chemokines and other mediators. Studies in both humans and animal models indicate that imbalances in these inflammatory mediators are associated with cancer development. We used a multistage model of SCC to examine the involvement of elastase (ELA), myeloperoxidase (MPO), nitric oxide (NO), cytokines (IL-6, IL-10, IL-13, IL-17, TGF-β and TNF-α), and neutrophils and macrophages in tumour development. ELA and MPO activity and NO, IL-10, IL -17, TNF-α and TGF-β levels were increased in the precancerous microenvironment. ELA and MPO activity and NO, IL-10, IL -17, TNF-α and TGF-β levels were increased in the precancerous microenvironment. Significantly higher levels of IL-6 and lower levels of IL-10 were detected at 4 weeks following 7,12-Dimethylbenz(a)anthracene (DMBA) treatment. Similar levels of IL-13 were detected in the precancerous microenvironment compared with control tissue. We identified significant increases in the number of GR-1+ neutrophils and F4/80+/GR-1- infiltrating cells in tissues at 4 and 8 weeks following treatment and a higher percentage of tumour-associated macrophages (TAM) expressing both GR-1 and F4/80, an activated phenotype, at 16 weeks. We found a significant correlation between levels of IL-10, IL-17, ELA, and activated TAMs and the lesions. Additionally, neutrophil infiltrate was positively correlated with MPO and NO levels in the lesions. Our results indicate an imbalance of inflammatory mediators in precancerous SCC caused by neutrophils and macrophages and culminating in pro-tumour local tissue alterations.